TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
JK Biostatistics AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 256 | 267 | 260 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 14 | 49 | 73 |
EBITDA | 17 | 49 | 67 |
Total assets | 192 | 138 | 142 |
Current assets | 156 | 120 | 30 |
Current liabilities | 67 | 23 | 33 |
Equity capital | 124 | 115 | 109 |
- share capital | 9 | 9 | 10 |
Employees (average) | 3 | 3 | 2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 64.6% | 83.3% | 76.8% |
Turnover per employee | 85 | 89 | 130 |
Profit as a percentage of turnover | 5.5% | 18.4% | 28.1% |
Return on assets (ROA) | 7.3% | 35.5% | 51.4% |
Current ratio | 232.8% | 521.7% | 90.9% |
Return on equity (ROE) | 11.3% | 42.6% | 67.0% |
Change turnover | -11 | 27 | 14 |
Change turnover % | -4% | 11% | 6% |
Chg. No. of employees | 0 | 1 | 0 |
Chg. No. of employees % | 0% | 50% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.